Factors associated with COVID-19-related death using OpenSAFELY

Williamson, Elizabeth J., Walker, Alex J., Bhaskaran, Krishnan, Bacon, Seb, Bates, Chris, Morton, Caroline E., Curtis, Helen J., Mehrkar, Amir +22 more·2020·Nature

Cited by (1,015)

Items 701–800 of 1,015

  1. Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
    R. Houot, R. Levy, G. Cartron, P. Armand · 2020 · European Journal of Cancer
  2. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY
    Denyse D. Lutchmansingh, Melissa P. Knauert, Danielle E Antin-Ozerkis, Geoffrey Lowell Chupp, Lauren E. Cohn, Charles S. Dela Cruz, Lauren E. Ferrante, Erica L. Herzog, Jonathan L. Koff, Carolyn L. Rochester et al. · 2020 · CHEST Journal
  3. Ethnic-minority groups in England and Wales—factors associated with the size and timing of elevated COVID-19 mortality: a retrospective cohort study linking census and death records
    Daniel Ayoubkhani, Vahé Nafilyan, Chris White, Peter Goldblatt, Charlotte Hannah Gaughan, Louisa Blackwell, Nicky Rogers, Amitava Banerjee, Kamlesh K. Khunti, Myer Glickman et al. · 2020 · International Journal of Epidemiology
  4. Outcomes of COVID-19 in CKD Patients
    Haig H. Pakhchanian, Rahul Raiker, Amrita Mukherjee, Ahmad Khan, Shailendra Singh, Arka Chatterjee · 2021 · Clinical Journal of the American Society of Nephrology
  5. Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study
    Jesús Castilla, Marcela Guevara, Ana Miqueleiz, Fernando Baigorría, Carlos Ibero Esparza, Ana Navascués, Camino Trobajo‐Sanmartín, Iván Martínez‐Baz, Itziar Casado, Cristina Burgui et al. · 2021 · Journal of Clinical Medicine
  6. Colchicine for the treatment of COVID-19
    Agata Mikołajewska, Anna-Lena Fischer, Vanessa Piechotta, Anika Mueller, Maria‐Inti Metzendorf, Marie Becker, Elena Dorando, Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Rachel Riera et al. · 2021 · Cochrane Database of Systematic Reviews
  7. SARS-CoV-2 detection using quantum dot fluorescence immunochromatography combined with isothermal amplification and CRISPR/Cas13a
    Qin Zhang, Jiahao Li, Yue Li, Guolei Tan, Mei Sun, Yanke Shan, Yue Zhang, Xin Wang, Keyu Song, Rui Shi et al. · 2022 · Biosensors and Bioelectronics
  8. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
    Stefanie Reis, Maria‐Inti Metzendorf, Rebecca Kuehn, Maria Popp, Ildikó Gágyor, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel · 2022 · Cochrane Database of Systematic Reviews
  9. Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-analysis, & Public Policy Implications
    Andrew Levin, William Paul Hanage, Nana Owusu‐Boaitey, Kensington Cochran, Seamus P. Walsh, Gideon Meyerowitz‐Katz · 2020 · National Bureau of Economic Research
  10. SARS-CoV-2 and cancer: Are they really partners in crime?
    Peter A. van Dam, Manon Thirza Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren A.A. Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altıntaş, Jan Baptist Vermorken, Christof Vulsteke et al. · 2020 · Cancer Treatment Reviews
  11. Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors
    Jeanine J.S. Rutten, Anouk M. van Loon, Janine van Kooten, Laura W. van Buul, Karlijn J. Joling, Martin Smalbrugge, Cees M.P.M. Hertogh · 2020 · Journal of the American Medical Directors Association
  12. Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System
    Kathleen M. Andersen, Hemalkumar B. Mehta, Natasha Palamuttam, Daniel E. Ford, Brian Thomas Garibaldi, Paul G. Auwaerter, Jodi B Segal, G. Caleb Alexander · 2021 · Clinical Infectious Diseases
  13. Protection against severe infectious disease in the past
    ALEXANDER J MERCER · 2021 · Pathogens and Global Health
  14. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
    Fernando Gónzález‐Candelas, Marie‐Anne Shaw, Tung Gia Phan, Urmila Kulkarni‐Kale, Dimitrios N. Paraskevis, Fabio Luciani, Hirokazu Kimura, Manuela Sironi · 2021 · Infection Genetics and Evolution
  15. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study
    Matthew L. Bosworth, Daniel Ayoubkhani, Vahé Nafilyan, Josephine Foubert, Myer Glickman, Calum Davey, Hannah Kuper · 2021 · The Lancet Public Health
  16. COVID-19 Survival and its impact on chronic kidney disease
    Joshua D. Long, Ian A. Strohbehn, Rani Sawtell, Roby P. Bhattacharyya, Meghan E. Sise · 2021 · Translational research
  17. Common human genetic variants of APOE impact murine COVID-19 mortality
    Benjamin Nils Ostendorf, Mira A. Patel, Jana Bilanovic, Hans-Heinrich Hoffmann, Sebastian E. Carrasco, Charles M. Rice, Sohail F. Tavazoie · 2022 · Nature
  18. The role of immune activation and antigen persistence in acute and long COVID
    Skye Opsteen, Jacob K. Files, Tim Fram, Nathan B. Erdmann · 2023 · Journal of Investigative Medicine
  19. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review.
    Edward P K Parker, Shalini Desai, Melanie Marti, Hanna Nohynek, David C. Kaslow, Sonali Kochhar, Katherine L. O’Brien, Joachim Hombach, Annelies Wilder‐Smith · 2022 · PubMed Central
  20. Do genetic polymorphisms in angiotensin converting enzyme 2 ( ACE2 ) gene play a role in coronavirus disease 2019 (COVID-19)?
    Giuseppe Lippi, Carl J. Lavie, Brandon Michael Henry, Fabián Sanchis‐Gomar · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
  21. Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
    Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frélaut, Aurélien Noret, Audrey Bellesœur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat et al. · 2020 · JNCI Cancer Spectrum
  22. Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
    Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Brian Godman, Santosh Kumar, Salequl Islam, Iffat Jahan, Mainul Haque · 2020 · Infection and Drug Resistance
  23. “This may be a really good opportunity to make the world a more autism friendly place”: Professionals’ perspectives on the effects of COVID-19 on autistic individuals
    Debbie Spain, David Mason, J. Simone, Laura Stoppelbein, Susan Williams White, Francesca G. E. Happe · 2021 · Research in Autism
  24. Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort
    Thomas E. Yates, Francesco Zaccardi, Nazrul Islam, Cameron Razieh, Clare L. Gillies, Claire Alexandra Lawson, Yogini Chudasama, Alex V. Rowlands, Melanie Jane Davies, Annemarie Beth Docherty et al. · 2021 · Obesity
  25. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country
    Tigist Workneh Leulseged, Ishmael S. Hassen, Birhanu Teshome Ayele, Yakob Gebregziabher Tsegay, Daniel S. Abebe, Mesay G. Edo, Endalkachew H. Maru, Wuletaw Chane Zewde, Lydia K. Naylor, Dejene F. Semane et al. · 2021 · PLoS ONE
  26. Initial Effects of COVID-19 on Patients with ESKD
    Eric D. Weinhandl, James B. Wetmore, Yi Peng, Jiannong Liu, David T. Gilbertson, Kirsten L. Johansen · 2021 · Journal of the American Society of Nephrology
  27. Improving the digital skills of older adults in a COVID-19 pandemic environment
    Kerolyn Ramos Garcia, Liliana Rodrigues, Leonardo Costa Pereira, Grażyna Busse, Madara Mara Irbe, Marta Almada, Cindy Christensen, Luís Midão, Inês Dias, Daniel Heery et al. · 2021 · Educational Gerontology
  28. Highlights in the advances of chronic rhinosinusitis
    Xinni Xu, Sietze Reitsma, De Yun Wang, Wytske Johanna Fokkens · 2021 · Allergy
  29. Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach
    Angela Danielle Iuliano, Howard H. Chang, Neha N Patel, Ryan Threlkel, Krista L. Kniss, Jeremy S. Reich, Molly K. Steele, Aron J. Hall, Alicia M. Fry, Carrie Reed · 2021 · The Lancet Regional Health - Americas
  30. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19
    Marine Gérard, Meliha Mahmutovic, Aurélie Malgras, Niasha Michot, Nicolas Scheyer, R. Jaussaud, Phi‐Linh Nguyen‐Thi, Didier Quilliot · 2021 · Nutrients
  31. Smoking and the risk of COVID-19 in a large observational population study
    Ariel Israel, Elan Feldhamer, Amnon Lahad, Diane Levin‐Zamir, Gil Lavie · 2020 · medRxiv
  32. Māori and Pacific People in New Zealand have higher risk of hospitalisation for COVID-19
    Nicholas Steyn, Rachelle N. Binny, Kate Hannah, Shaun C. Hendy, Alex James, Audrey G. Lustig, Kannan Ridings, Michael John Plank, Andrew A. Sporle · 2020 · medRxiv
  33. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department
    Francisco Javier Martín‐Sánchez, Enrique del Toro, Eduardo Bajo Cardassay, Adrián Valls Carbó, Federico Miguel Cuesta Triana, Marta Vigara García, Pedro Gil Madrona, Amanda López Picado, Carmen Martínez-Valero, Juan de Dios Miranda et al. · 2020 · European Geriatric Medicine
  34. A Valid Warning or Clinical Lore: an Evaluation of Safety Outcomes of Remdesivir in Patients with Impaired Renal Function from a Multicenter Matched Cohort
    Tyler W. Ackley, Dayna S. McManus, Jeffrey E. Topal, Brian Cicali, Sunish Shah · 2020 · Antimicrobial Agents and Chemotherapy
  35. COVID-19 and disparities affecting ethnic minorities
    Daniel R. Morales, Sarah Naz Ali · 2021 · The Lancet
  36. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
    Vincent Olivier Mallet, Nathanaël Beeker, Samir Bouam, Philippe Sogni, Stanislas Pol, Vincent Mallet, Nathanaël Beeker, Samir Bouam, Hélène Fontaine, Marion Corouge et al. · 2021 · Journal of Hepatology
  37. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative
    Guillaume Butler‐Laporte, Gundula Povysil, Jack A. Kosmicki, Elizabeth T. Cirulli, Theodore G. Drivas, Simone Furini, Chadi Saad, Axel Schmidt, Pawel Olszewski, Urszula Korotko et al. · 2022 · PLoS Genetics
  38. Epidemiology and Clinical Presentation of COVID-19 in Older Adults
    Yasin Abul, Ciera Leeder, Stefan Gravenstein · 2022 · Clinics in Geriatric Medicine
  39. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques
    Tian‐Zhang Song, 中国科学院昆明动物研究所,中国科学院动物模型与人类疾病机制重点实验室,KIZ-CUHK常见疾病生物资源与分子研究联合实验室,云南 昆明650223,中国, Hong‐Yi Zheng, Jian-Bao Han, Lin Jin, Xiang Sheng Yang, Feng‐Liang Liu, Rong‐Hua Luo, Ren‐Rong Tian, Hourong Cai et al. · 2020 · 动物学研究
  40. Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis
    Yuanyuan Wang, Jingjing Chen, Wei Chen, Ling Liu, Mei Dong, Juan Ji, Die Hu, Nianzhi Zhang · 2020 · International Archives of Allergy and Immunology
  41. Hyponatremia is associated with poor outcome in COVID-19
    Hugo De Carvalho, Thibault Letellier, Matilde Karakachoff, Geoffrey Desvaux, Hélène Caillon, Emmanuelle Papuchon, Maxime Bentoumi-Loaec, Nesrine Benaouicha, Emmanuel Canet, Guillaume Chapelet et al. · 2021 · Journal of Nephrology
  42. Race, ethnicity and COVID-19 vaccination: a qualitative study of UK healthcare staff
    Charlotte Woodhead, Juliana Onwumere, Rebecca D. Rhead, Monalisa Bora-White, Zoe Chui, Naomi Clifford, Luke Connor, Cerisse Gunasinghe, Hannah Harwood, Paula Meriez et al. · 2021 · Ethnicity and Health
  43. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
    Emanuel Zitt, Tamara Davidovic, Judith Schimpf, Armin Abbassi-Nik, Beatrix Mutschlechner, Hanno Ulmer, Magdalena Anna Benda, Hannelore Sprenger-Mähr, Thomas L. Winder, Karl Lhotta · 2021 · Frontiers in Immunology
  44. Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
    Anna R. Kahkoska, Trine Julie Abrahamsen, G. Caleb Alexander, Tellen D. Bennett, Christopher G. Chute, Melissa Anne Haendel, Klara Rachel Klein, Hemalkumar B. Mehta, Joshua D. Miller, Richard A. Moffitt et al. · 2021 · Diabetes Care
  45. Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis
    Ashutosh N. Aggarwal, Ritesh Agarwal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Inderpaul Singh Sehgal, Valliappan Muthu · 2021 · PLoS ONE
  46. A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load
    Michael Lawrence Dougan, Masoud Azizad, Bharat Mocherla, Robert Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry N. Heller, Jason Morris et al. · 2021 · Clinical Infectious Diseases
  47. Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19
    Jiuling Li, Aowen Tian, Haoxue Zhu, Lanlan Chen, Jianping Wen, Wanqing Liu, Peng Chen · 2022 · Clinical Gastroenterology and Hepatology
  48. Molecular mimicry in multisystem inflammatory syndrome in children
    Aaron Bodansky, Robert C. Mettelman, Joseph J. Sabatino, Sara E. Vazquez, Janet S. Chou, Tanya Novak, Kristin L. Moffitt, Haleigh S. Miller, Andrew F. Kung, Elze Rackaityte et al. · 2024 · Nature
  49. Increased vulnerability to COVID‐19 in chronic kidney disease
    Nicholas Carlson, Karl Emil Nelveg-Kristensen, Ellen Linnea Freese Ballegaard, Bo Feldt‐Rasmussen, Mads Hornum, Anne‐Lise Kamper, Gunnar Gislason, Christian Tobias Torp-Pedersen · 2021 · Journal of Internal Medicine
  50. Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial
    Pamela R. Kearns, Stefan Siebert, Michelle Kay Willicombe, Charlotte Gaskell, Amanda J. Kirkham, Sarah J. Pirrie, Sarah Jane Bowden, Sophia Magwaro, Ana Hughes, Zixiang Lim et al. · 2021 · SSRN Electronic Journal
  51. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
    David James Pinato, Alvin J. X. Lee, Federica Biello, Elia Seguí, Anna Carbó, Riccardo Bruna, Mark Bower, Gianpiero Rizzo, Sarah Benafif, Carme Carmona et al. · 2020 · Cancers
  52. Respiratory patient experience of measures to reduce risk of COVID-19: findings from a descriptive cross-sectional UK wide survey
    Keir E. J. Philip, Andrew Cumella, Joe Farrington-Douglas, Michael Laffan, Nicholas S Hopkinson · 2020 · BMJ Open
  53. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
    Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud E. Louis, Alain Michils, Rudi Peché, Charles Pilette, Peter Rummens, Daniël Schuermans, Hélène Simonis et al. · 2020 · European Respiratory Journal
  54. Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020
    Shin‐Woo Kim, Seung-Mee Kim, Yu Kyung Kim, Jong-Yeon Kim, Yu‐Mi Lee, Bong-Ok Kim, Suhyun Hwangbo, Taesung Park · 2020 · Journal of Korean Medical Science
  55. Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
    Simone Bastrup Israelsen, Anton Pottegård, Håkon Sandholdt, Sten Madsbad, Reimar Wernich Thomsen, Thomas Benfield · 2021 · Diabetes Obesity and Metabolism
  56. Neurobiology of COVID-19: how can the virus affect the brain?
    Jaqueline S. Generoso, Joao Luis Barichello de Quevedo, Matias Cattani, Bruna França Lodetti, Lucas Sousa, Allan Collodel, Alexandre Paim Díaz, Felipe Dal‐Pizzol · 2021 · Brazilian Journal of Psychiatry
  57. Severe mental illness is associated with increased mortality and severe course of COVID‐19
    Carlo Alberto Barcella, Christoffer Polcwiartek, Grimur Høgnason Mohr, Gethin W. Hodges, Kathrine Bach Søndergaard, Casper Niels Bang, Mikkel Porsborg Andersen, Emil Loldrup Fosbøl, Lars Køber, Morten Schou et al. · 2021 · Acta Psychiatrica Scandinavica
  58. BMI and pneumonia outcomes in critically ill COVID‐19 patients: An international multicenter study
    Mikaël Chetboun, Violeta Raverdy, Julien Labreuche, Arthur Simonnet, Florent Wallet, Cyrielle Caussy, Massimo M. Antonelli, Antonio Artigas, Gemma Gomà, Ferhat Meziani et al. · 2021 · Obesity
  59. Community factors and excess mortality in first wave of the COVID-19 pandemic in England
    Bethan Davies, Brandon L. Parkes, James E. Bennett, Daniela Fecht, Marta Blangiardo, Majid Ezzati, Paul Elliott · 2021 · Nature Communications
  60. Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic
    Nora Mahmoud El-Rashidy, Samir Mohamed Abdelrazek, Tamer Abuhmed, Eslam Amer, Farman Ali, Jong Wan Hu, Shaker El–Sappagh · 2021 · Diagnostics
  61. Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort
    Josiane Warszawski, Anne‐Lise Beaumont, Rémonie Seng, Xavier Nicolas de Lamballerie, Delphine Rahib, Nathalie Lydié, Rémy Slama, Sylvain Durrleman, Philippe Raynaud, Patrick Sillard et al. · 2022 · BMC Infectious Diseases
  62. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform
    Krishnan Bhaskaran, Christopher T. Rentsch, George Hickman, William J. Hulme, Anna Schultze, Helen J Curtis, Kevin Wing, Charlotte Warren‐Gash, Laurie A. Tomlinson, Chris J Bates et al. · 2022 · PLoS Medicine
  63. Relationship between asthma and severe COVID-19: a national cohort study
    Ted Dolby, Vahé Nafilyan, Ann Morgan, Constantinos Kallis, Aziz Sheikh, Jennifer Kathleen Quint · 2022 · Thorax
  64. Clinical Characteristics and Risk Factors for COVID-19 Infection and Disease Severity: A Nationwide Observational Study in Estonia
    Tatjana Meister, Heti Pisarev, Raivo Kolde, Ruth Kalda, Kadri Suija, Lili A. Milani, Liis Karo-Astover, Marko Piirsoo, Anneli Uusküla · 2021 · PLoS ONE
  65. T cell immune memory after covid-19 and vaccination
    Lulu Wang, Alexander R. Nicols, Lance C. W. Turtle, Alex G Richter, Christopher James Arthur Duncan, Susanna Jane Dunachie, Paul Klenerman, Rebecca Payne · 2023 · BMJ Medicine
  66. Mathematical modelling to inform New Zealand's COVID‐19 response
    Shaun C. Hendy, Nicholas Steyn, Alex James, Michael John Plank, Kate Hannah, Rachelle N. Binny, Audrey G. Lustig · 2021 · Journal of the Royal Society of New Zealand
  67. Covid-19 and ethnic minorities: an urgent agenda for overdue action
    Kamlesh K. Khunti, Lucinda Platt, Ash C. Routen, Kamran Ali Abbasi · 2020 · BMJ
  68. COVID-19 and ethnicity: A novel pathophysiological role for inflammation
    Abhinav Vepa, Joseph P. Bae, Faheem Ahmed, Manish Pareek, Kamlesh K. Khunti · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  69. Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic
    Eugenie Younger, Alannah Smrke, Emma K. Lidington, Sheima Farag, Katrina M. Ingley, Neha Chopra, Alessandra Maleddu, Yolanda Sydney Augustin, Eve Merry, Roger Wilson et al. · 2020 · Cancers
  70. Strengthening the UK primary care response to covid-19
    Sophie Elizabeth Park, Josephine Elliott, Anita Berlin, Julia Hamer-Hunt, Andy Haines · 2020 · BMJ
  71. Continuous Positive Airway Pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: A retrospective cohort study
    Sophie Alviset, Quentin Riller, Jérôme Aboab, Kelly Dilworth, Pierre-Antoine Billy, Yannis Lombardi, Mathilde Azzi, Luis Ferreira Vargas, Laurent Lainé, Mathilde Lermuzeaux et al. · 2020 · PLoS ONE
  72. Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension
    James Peter Sheppard, Brian David Nicholson, Joseph Jonathan Lee, Dylan McGagh, Julian Sherlock, Constantinos Koshiaris, Jason Lee Oke, Nicholas Robert Jones, William Hinton, Laura Catherine Armitage et al. · 2020 · Hypertension
  73. Serum levels of ACE2 are higher in patients with obesity and diabetes
    Valur Emilsson, Elias Freyr Gudmundsson, Thor Aspelund, Brynjolfur G. Jonsson, Alexander Guðjónsson, Lenore J. Launer, John R. Lamb, Valborg Guðmundsdóttir, Lori L. Jennings, Vilmundur G. Gudnason · 2020 · Obesity Science & Practice
  74. How Well the Government of Nepal Is Responding to COVID-19? An Experience From a Resource-Limited Country to Confront Unprecedented Pandemic
    Binod Rayamajhee, Anil Pokhrel, Gopiram Syangtan, Saroj Khadka, Bhupendra Lama, Lal Bahadur Rawal, Suresh Mehata, Shyam Kumar Mishra, Roshan Pokhrel, Uday Narayan Yadav · 2021 · Frontiers in Public Health
  75. COVID-19 and rheumatoid arthritis
    Kristin M. D'Silva, Zachary Scott Wallace · 2021 · Current Opinion in Rheumatology
  76. Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
    Jassin Rashidi‐Alavijeh, Alexandra Frey, Moritz Passenberg, Johannes Korth, Jaqueline Zmudzinski, Olympia Evdoxia Anastasiou, Fuat Hakan Saner, Michael Jahn, Christian Markus Lange, Katharina Willuweit · 2021 · Vaccines
  77. Exercise Is Medicine for Immune Function: Implication for COVID-19
    David Christopher Nieman · 2021 · Current Sports Medicine Reports
  78. Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
    Inbal Farkash, Tali Feferman, Noy Cohen Saban, Yahel Avraham, David Morgenstern, Grace Mayuni, Natasha Barth, Yaniv Lustig, Liron Miller, Dror S. Shouval et al. · 2021 · Cell Reports
  79. Infection fatality rate of COVID-19 in community-dwelling elderly populations
    Cathrine Axfors, John P. A. Ioannidis · 2022 · European Journal of Epidemiology
  80. Long-Term Mortality Following COVID-19 Infection: A National Cohort Study From Estonia
    Anneli Uusküla, Tuuli Jürgenson, Heti Pisarev, Raivo Kolde, Tatjana Meister, Anna Tisler, Kadri Suija, Ruth Kalda, Marko Piirsoo, Krista Fischer · 2022 · The Lancet Regional Health - Europe
  81. Lessons from the COVID-19 pandemic for accelerating sustainable development
    Cathryn C. Tonne · 2020 · Environmental Research
  82. A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
    Naoko Iwata‐Yoshikawa, Nozomi Shiwa, Tsuyoshi Sekizuka, Kaori Sano, Akira Ainai, Takuya Hemmi, Michiyo Kataoka, Makoto Kuroda, Hideki Hasegawa, Tadaki Suzuki et al. · 2022 · Science Advances
  83. Shielding from covid-19 should be stratified by risk
    George Davey Smith, David J. Spiegelhalter · 2020 · BMJ
  84. Men and COVID-19: the aftermath
    Alan White · 2020 · Postgraduate Medicine
  85. A case-control and cohort study to determine the relationship between ethnic background and severe COVID-19
    Rosita Zakeri, Rebecca Bendayan, Mark J. Ashworth, Daniel M. Bean, Hiten Dodhia, Stevo Durbaba, Kevin O’Gallagher, Claire Palmer, Vasa Ćurčin, Elizabeth Aitken et al. · 2020 · EClinicalMedicine
  86. Pediatric asthma and COVID‐19: The known, the unknown, and the controversial
    Elissa Michele Abrams, Ian P Sinha, Ricardo M. Fernandes, Daniel B. Hawcutt · 2020 · Pediatric Pulmonology
  87. Combining Antivirals and Immunomodulators to Fight COVID-19
    Vincent Feuillet, Bruno Canard, Alain Trautmann · 2020 · Trends in Immunology
  88. COVID-19: An overview and a clinical update
    Arunkumar Krishnan, James P. Hamilton, Saleh A. Alqahtani, Tinsay A. Woreta · 2020 · World Journal of Clinical Cases
  89. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic
    Alvin J. X. Lee, Karin R. Purshouse · 2021 · British Journal of Cancer
  90. Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review
    Jan M Stratil, Renke Lars Biallas, Jacob Burns, Laura Arnold, Karin Geffert, Angela M. Kunzler, Ina Monsef, Julia Stadelmaier, Katharina J. Pascale Wabnitz, Tim Litwin et al. · 2021 · Cochrane Database of Systematic Reviews
  91. Uncovering the signalling, structure and function of the 20‐HETE‐GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75
    Jonathan V. Pascale, Eon Joo Park, Adeniyi Michael Adebesin, John Russell Falck, Michal Laniado Schwartzman, Victor G Garcia · 2021 · British Journal of Pharmacology
  92. Educational Attainment Decreases the Risk of COVID-19 Severity in the European Population: A Two-Sample Mendelian Randomization Study
    Masahiro Yoshikawa, Kensuke Asaba · 2021 · Frontiers in Public Health
  93. Diabetes and COVID19: a bidirectional relationship
    Ranjit Unnikrishnan I, Anoop Misra · 2021 · Nutrition and Diabetes
  94. Epidemiological and clinical characteristics of early COVID-19 cases, United Kingdom of Great Britain and Northern Ireland
    Nicki L. Boddington, André Charlett, Suzanne Elgohari, Jemma L Walker, Helen I McDonald, Chloe Byers, Laura Coughlan, Tatiana Garcia Vilaplana, Rosie Whillock, Mary Sinnathamby et al. · 2020 · Bulletin of the World Health Organization
  95. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
    Sabine Haggenburg, Birgit Ilja Lissenberg-Witte, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Dennis M. de Rooij, Johan van Meerloo, Jacqueline J Cloos, Neeltje A. Kootstra et al. · 2022 · Blood Advances
  96. Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
    Csilla Várnai, Claire Palles, Roland R. Arnold, Helen M. Curley, Karin R. Purshouse, Vinton W.T. Cheng, Stephen W. Booth, Naomi A. Campton, Graham P. Collins, Daniel Johnathan Hughes et al. · 2022 · JAMA Network Open
  97. Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study
    Malin Sund, Osvaldo Fonseca‐Rodríguez, Andreas Josefsson, Karin Welén, Anne-Marie Connolly-Andersen · 2022 · BMJ Open
  98. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
    ACTIV-3/TICO Study Group, Angela J. Rogers, Deborah N. Wentworth, Andrew N. Phillips, Kathryn Shaw‐Saliba, Robin L. Dewar, Neil R. Aggarwal, Abdel G. Babiker, Weizhong Chang, Nila J. Dharan et al. · 2022 · Annals of Internal Medicine
  99. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
    Santenna Chenchula, Kota Vidyasagar, Saman Pathan, Sushil Kumar Sharma, Madhav Rao Chavan, Akshaya Srikanth Bhagavathula, R. Padmavathi, M. Manjula, Manik Chhabra, Rupesh Gupta et al. · 2023 · Scientific Reports
  100. Prospective, Longitudinal Pilot Study
    Tiarnán D L Keenan, Michaella Goldstein, Dafna Goldenberg, Dinah Zur, Shiri Shulman, Anat Loewenstein · 2021 · Ophthalmology Science